Indomethacin PK-PD in Extremely Preterm Neonates

NCT04025177 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Halted due to feasibility issues

Conditions

Patent Ductus Arteriosus After Premature Birth

Interventions

DRUG: Indomethacin Injection

Sponsor

University of Manitoba

Collaborators

[object Object]
[object Object]
[object Object]